Physician profile
Matthew Brown
NPI 1841283496
$4,882.54
in general payments reported to CMS, 2019-2025
15 companies · $30.25 in 2025
The $30.25 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,447 · 2020: $181 · 2021: $17.98 · 2022: $53.61 · 2023: $38.50 · 2024: $114 · 2025: $30.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $3,047.08 | 2019-2020 | |
| Inspire Medical Systems, INC. | $1,109.18 | 2019 | |
| Angiodynamics, INC. | $183.12 | 2023-2025 | Auryon Laser System 100-120 Vac |
| Stryker Corporation | $148.78 | 2019-2020 | |
| Acclarent, INC | $112.92 | 2019-2022 | |
| Karl Storz Endoscopy-America | $60.06 | 2019-2022 | |
| Smith+Nephew, INC. | $43.73 | 2020 | |
| Intersect Ent, INC. | $40.97 | 2019 | |
| Covidien LP | $36.04 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $33.18 | 2019 | |
| Genzyme Corporation | $20.81 | 2019 | |
| Acera Surgical, INC. | $16.18 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $15.96 | 2019 | |
| Jubilant Hollisterstier LLC | $14.53 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.